Search

everythinglearnresearchcommunity

for

Search:↓

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

Finasteride safely lowers DHT levels without affecting testosterone.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

BRL 7660, once studied for male contraception, showed promise as an acne treatment but was not developed further due to competing drugs.

Finasteride helps treat hair loss by blocking enzyme activity.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

New treatments for PCOS focus on managing symptoms and improving fertility.

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Hirsutism causes significant psychological distress in women.

Recent hair loss research shows some progress, especially in understanding male pattern baldness, but effective treatments for many types of hair loss are still lacking.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

Testosterone is crucial for development, growth, and various body functions in mammals.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Cyproterone acetate plus ethinyl estradiol is generally more effective in treating hirsutism, but consider side effects and patient characteristics.